Navigation Links
Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
Date:2/9/2010

BOSTON AND LA JOLLA, CA-- Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.

The discovery of the antibodies was first reported by Wayne A. Marasco, MD, PhD, associate professor of medicine at Dana-Farber and Harvard Medical School; Robert Liddington, PhD, professor and director, Infectious and Inflammatory Disease Center at Sanford-Burnham; and Ruben Donis, PhD, chief of the Molecular Virology and Vaccines Branch at the Centers for Disease Control and Prevention, in Nature Structural and Molecular Biology in February 2009.

They demonstrated that the newly identified antibodies attach to the stem region of the viral proteins (hemagglutinin), rather than to the head region, the standard target of current influenza vaccines. Binding to the highly conserved stem region prevents changes in the protein that are necessary for viral entry into the host cell, thereby inhibiting further infection of host cells and the rise of escape mutants. Standard influenza vaccines that consist of an attenuated, or killed, virus typically stimulate antibodies against the protein's head. These vaccines are less effective as the head region is prone to change, leading to the rise of forms of the virus that can evade neutralizing antibodies.

Complete terms of the agreement are not public, but Dana-Farber and Sanford-Burnham will receive license fees and may receive milestone payments and royalties.


'/>"/>
Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
2. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
3. Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
4. Dana-Farber Cancer Institute Chooses MicroStrategy for Clinical Operations and Clinical Research Reporting Applications
5. InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways
6. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
7. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
8. LifeNet Health Establishes The Skin & Wound Allograft Institute
9. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
10. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
11. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2020)... ... 22, 2020 , ... Although many people thrive on praise, ... reveals that some people who dismiss compliments struggle with their sense of self-worth, ... took the Emotional Intelligence Test, Queendom researchers focused on two distinct ...
(Date:2/21/2020)... MIAMI LAKES, Fla. (PRWEB) , ... February 21, 2020 , ... Representatives with Bay-Bay ... proud to announce the launch of Bay-Bay Water’s new company logo as part of the ... These logo redesign come at a time when the company is expanding its national reach. ...
(Date:2/21/2020)... ... February 21, 2020 , ... The American ... Cancer Leaders’ Summit in Boston, MA, in October 2021. The prestigious, invitation-only event—organized ... including prime ministers, ministers of health, city and industry leaders, senior executives and ...
(Date:2/20/2020)... , ... February 20, 2020 , ... R3 Stem Cell, ... was able to complete 70 complimentary stem cell procedures on military veterans ... therapies at no cost. , At the R3 Stem Cell Training Course for doctors ...
(Date:2/19/2020)... ... February 19, 2020 , ... Spaulding Youth ... $10,000.00 from the Doug Flutie, Jr. Foundation for Autism. The grant will directly ... , The physical fitness program will include the hiring of a fitness professional ...
Breaking Medicine News(10 mins):
(Date:2/28/2020)... ... February 27, 2020 , ... ... sciences in the Salesforce® ecosystem, announced today that its Unified, End-to-End Document and ... Certified status demonstrates that the zPaper Document and Data Automation Platform for Salesforce®, ...
(Date:2/28/2020)... ... , ... This Women’s History Month, the VA Maryland Health Care System invites ... Veterans Affairs, Women’s History Month means more than just celebrating our women veterans – ... chapters of their story,” said VA Chief of Staff Pam Powers. “We will continue ...
(Date:2/28/2020)... ... February 27, 2020 , ... Special Learning, Inc. ... with the mission to bring quality ABA intervention to the world. The ... suite comprised of curriculum and teaching materials to enable unfettered global access to ...
Breaking Medicine Technology: